Literature DB >> 16860862

Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia.

H Nishizawa1, K Pryor-Koishi, T Kato, H Kowa, H Kurahashi, Y Udagawa.   

Abstract

Although it has been well documented that pre-eclampsia is caused by a combination of maternal and fetal susceptibility genes, little is known about the precise etiology of this complicated disorder. To investigate how the expression of fetal genes contributes to the mechanisms underlying the progression of this disease, we have analyzed differentially expressed genes using placentas from 13 normal pregnancies and 14 pregnancies with severe pre-eclampsia. We performed genome-wide expression profiling using high-density oligonucleotide microarrays, followed by validation using real-time PCR. Among the 47,000 genes that were screened in the microarray, 137 genes were found to be differentially expressed between normal and pre-eclamptic tissues. Among these candidates, 70 were up-regulated and 67 were down-regulated. The up-regulated genes included leptin and inhibin A, which are well-known biological markers for pre-eclampsia, as well as FLT1, which was recently proved to be tightly linked with the etiology of this disease. Gene ontology analysis further revealed several biological processes that could be associated with the development of pre-eclampsia, including response to stress, host-pathogen interactions, lipid metabolism, and carbohydrate metabolism. Analyses of biological mechanisms highlighted some important pathways that may be involved in this disorder, such as the TGF-beta and CEBPA-related pathways. Furthermore, when our present subjects were classified as either severe cases of early onset or late onset pre-eclampsia, the expression of 11 genes could be correlated with the severity of this disorder. These genes may therefore prove to be novel biological markers by which the severity of this condition could be predicted. Our data are likely to be a useful future resource in the elucidation of the disease-process and in the identification of novel markers for pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860862     DOI: 10.1016/j.placenta.2006.05.010

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  65 in total

1.  DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia.

Authors:  Ryan Kc Yuen; Maria S Peñaherrera; Peter von Dadelszen; Deborah E McFadden; Wendy P Robinson
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

2.  Fetal growth patterns in pregnancy-associated hypertensive disorders: NICHD Fetal Growth Studies.

Authors:  Julio Mateus; Roger B Newman; Cuilin Zhang; Sarah J Pugh; Jagteshwar Grewal; Sungduk Kim; William A Grobman; John Owen; Anthony C Sciscione; Ronald J Wapner; Daniel Skupski; Edward Chien; Deborah A Wing; Angela C Ranzini; Michael P Nageotte; Nicole Gerlanc; Paul S Albert; Katherine L Grantz
Journal:  Am J Obstet Gynecol       Date:  2019-06-19       Impact factor: 8.661

3.  Differential placental gene expression in preeclampsia.

Authors:  Daniel A Enquobahrie; Margaret Meller; Kenneth Rice; Bruce M Psaty; David S Siscovick; Michelle A Williams
Journal:  Am J Obstet Gynecol       Date:  2008-06-04       Impact factor: 8.661

Review 4.  Imprinted and X-linked non-coding RNAs as potential regulators of human placental function.

Authors:  Sam Buckberry; Tina Bianco-Miotto; Claire T Roberts
Journal:  Epigenetics       Date:  2013-09-30       Impact factor: 4.528

5.  Changes of placental syndecan-1 expression in preeclampsia and HELLP syndrome.

Authors:  Szilvia Szabo; Yi Xu; Roberto Romero; Tibor Fule; Katalin Karaszi; Gaurav Bhatti; Tibor Varkonyi; Ildiko Varkonyi; Tibor Krenacs; Zhong Dong; Adi L Tarca; Tinnakorn Chaiworapongsa; Sonia S Hassan; Zoltan Papp; Ilona Kovalszky; Nandor Gabor Than
Journal:  Virchows Arch       Date:  2013-06-27       Impact factor: 4.064

6.  Mining the literature for genes associated with placenta-mediated maternal diseases.

Authors:  Laritza M Rodriguez; Stephanie M Morrison; Kathleen Greenberg; Dina Demner Fushman
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

7.  Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease.

Authors:  K Junus; M Centlow; A-K Wikström; I Larsson; S R Hansson; M Olovsson
Journal:  Mol Hum Reprod       Date:  2011-10-19       Impact factor: 4.025

8.  Maternal peripheral blood gene expression in early pregnancy and preeclampsia.

Authors:  Daniel A Enquobahrie; Chunfang Qiu; Seid Y Muhie; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2010-12-29

9.  Gene expression profiling of placentas affected by pre-eclampsia.

Authors:  Anne Mette Hoegh; Rehannah Borup; Finn Cilius Nielsen; Steen Sørensen; Thomas V F Hviid
Journal:  J Biomed Biotechnol       Date:  2010-03-03

10.  Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis.

Authors:  Tibor Várkonyi; Levente Lázár; Attila Molvarec; Nándor Gábor Than; János Rigó; Bálint Nagy
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.